当前位置:首页 - 行情中心 - 祥生医疗(688358) - 财务分析 - 利润表

祥生医疗

(688358)

  

流通市值:34.83亿  总市值:34.83亿
流通股本:1.12亿   总股本:1.12亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入236,154,283.59127,713,897.36468,697,167.84362,245,220.14
  营业收入236,154,283.59127,713,897.36468,697,167.84362,245,220.14
二、营业总成本161,873,289.9583,307,450.65327,751,586.51265,916,746.04
  营业成本92,936,644.2549,387,867.06192,382,017.25147,964,861.72
  税金及附加1,179,164.15604,543.034,046,143.783,612,804.07
  销售费用27,924,657.9712,849,734.0154,999,266.739,476,204.72
  管理费用15,529,167.977,770,022.7337,633,830.1127,172,040.53
  研发费用37,613,050.6117,456,907.9779,633,906.1661,760,390.24
  财务费用-13,309,395-4,761,624.15-40,943,577.49-14,069,555.24
  其中:利息费用92,215.1869,941.5378,743.71297,302.28
  其中:利息收入16,673,694.957,197,249.9231,197,587.6520,523,681.22
三、其他经营收益
  加:公允价值变动收益95,763.77141,979.83170,984.75263,783.4
  加:投资收益1,953,564.51910,805.646,119,986.844,784,941.62
  资产处置收益3,156,901.27993,435.764,612,503.983,149,775.04
  资产减值损失(新)-2,501,971.97-571,804.57-4,561,745.68-974,947.4
  信用减值损失(新)-2,087,096.45-1,262,698.66-1,973,356.27-3,864,255.69
  其他收益4,770,022.112,578,545.4411,986,108.288,203,394.72
四、营业利润79,668,176.8847,196,710.15157,300,063.23107,891,165.79
  加:营业外收入148,333.26311.9994,545.687,000.6
  减:营业外支出314,566.58119,462.34548,386.04245,441.91
五、利润总额79,501,943.5647,077,559.8156,846,222.87107,652,724.48
  减:所得税费用9,805,622.685,463,029.4816,341,080.299,244,171.78
六、净利润69,696,320.8841,614,530.32140,505,142.5898,408,552.7
(一)按经营持续性分类
  持续经营净利润69,696,320.8841,614,530.32140,505,142.5898,408,552.7
(二)按所有权归属分类
  归属于母公司股东的净利润69,696,320.8841,614,530.32140,505,142.5898,408,552.7
  扣除非经常损益后的净利润63,825,981.3938,872,803.38127,117,573.5489,369,760.75
七、每股收益
  (一)基本每股收益0.620.371.260.88
  (二)稀释每股收益0.620.371.260.88
八、其他综合收益-1,534,028.17-518,532.971,925,329.89-3,326,913.66
  归属于母公司股东的其他综合收益-1,534,028.17-518,532.971,925,329.89-3,326,913.66
九、综合收益总额68,162,292.7141,095,997.35142,430,472.4795,081,639.04
  归属于母公司股东的综合收益总额68,162,292.7141,095,997.35142,430,472.4795,081,639.04
公告日期2025-08-292025-04-252025-04-252024-10-31
审计意见(境内)标准无保留意见
TOP↑